How are Advancements in Pharmaceutical Sector Spearheading Demand for Animal Drug Compounding

Manufacturers of animal drug compounding products are expected to witness steady growth in demand over the coming years, with rise in requirement for oral, injectable, and topical routes of administration across regions. Demand for anti-infectives will rise the fastest, giving a boost to market expansion.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5796

As stated in a new report by Fact.MR, North America and Europe will emerge as leading regional markets for animal drug compounding, while Asia Pacific will exhibit the fastest growth throughout the forecast period of 2021 to 2031. The global animal drug compounding market is projected to progress at a moderate CAGR over the next ten years.

Key Takeaways from Market Study

• High requirement for anti-infectives likely to be witnessed.
• Oral and injectable segments to boost sales in terms of route of administration.
• Companion animal segment to emerge lucrative across regions.
• Capsule and suspension forms of dosage to augment demand growth.
• The United States remain a huge market for animal drug compounding.
• Germany to exhibit hegemony in Europe’s market for animal drug compounding.

For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=5796

• Asia Pacific to emerge the fastest-growing region for manufacturers of animal drug compounding products.
• The United Kingdom, China, South Korea, France, and Canada to remain high-potential markets throughout the forecast period.

Market Segmentation by Category

• Product
o Anti-Infectives
o Metronidazole
o Ketoconazole
o Other Antibiotics
o Anti-Inflammatory
o Prednisolone
o Other Anti-Inflammatory

For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/5796

• Route of Administration
o Oral Animal Drug Compounding
o Injectable Animal Drug Compounding
o Topical Animal Drug Compounding
o Rectal Animal Drug Compounding
o Ocular Animal Drug Compounding

• Animal Type
o Companion Animal
o Animal Drug Compounding for Dogs
o Animal Drug Compounding for Cats
o Animal Drug Compounding for Horses
o Animal Drug Compounding for Birds
o Others
o Livestock Animal

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Demand for Companion Animal Drugs Surging

Drug compounding products are highly required for companion animals such as dogs, cats, and others. With increase in inclination towards domestication of such animals, suppliers of animal drug compounding products are experiencing surge in demand around the globe.

According to a report titled “U.S. Pet Ownership Statistics”, published by the American Veterinary Medical Association, the percentage of households owning dogs in the United States is 38.4, while 25.4% of U.S. people have cats as their pets. This gives a glimpse of the rising demand for various animal drug compounding products around the globe, such as GI drugs, CNS agents, and others.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1940/global-animal-drug-compounding-market

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.